We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Exploring the Link Between the Triglyceride-Glucose Index and Hypertension Incidence in Japanese Adults

MedXY Editorial Team•Oct 2, 2025•Cardiology
cardiovascular riskHypertensionJapanese PopulationTriglyceride-Glucose Index

Study Background and Disease Burden

Hypertension remains a significant public health challenge, contributing to increased morbidity and mortality worldwide. In Japan, the prevalence of hypertension among adults is notably high, with estimates suggesting that approximately 43% of the adult population lives with high blood pressure. The rising incidence of hypertension is closely linked to lifestyle factors, including diet, physical inactivity, and metabolic disorders such as obesity and diabetes. Given the established role of metabolic disorders in the pathogenesis of hypertension, identifying reliable biomarkers that can predict hypertension risk is crucial for public health interventions and clinical management.

The triglyceride-glucose (TyG) index, a simple composite marker derived from triglyceride and glucose levels, has gained attention in recent years. Studies have suggested that it may serve as a surrogate marker for insulin resistance and cardiovascular risk. This investigation aimed to clarify the relationship between the TyG index and the incidence of hypertension among the Japanese population through a population-based observational study.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension ManagementRecent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.Sep 17, 2026Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient CohortStudy found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.Sep 17, 2026Subclinical Liver Disease as a Silent Driver of Cardiovascular Risk: Insights from a Large-Scale Prospective StudySubclinical liver disease, marked by steatosis, fibrosis, and functional impairment, independently and synergistically increases cardiovascular disease risk. Incorporating non-invasive liver biomarkers could enhance CVD risk prediction andSep 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Illuminating the Night: How Nighttime Light Exposure Impacts Cardiac Structure, Function, and Cardiovascular Risk
Nighttime light exposure over 3 lux is linked to adverse cardiac remodeling, subclinical functional decline, and increased cardiovascular events, partly mediated by shorter sleep duration, underscoring the importance of dark nights and slee
Sep 15, 2026
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women with Vasomotor Symptoms: Insights from the SWAN StudyInitiation of menopausal hormone therapy during perimenopause or early postmenopause in women with vasomotor symptoms is associated with a reduced cardiovascular risk, especially among Black women and those starting therapy within 10 yearsSep 13, 2026
Tropical Cyclones and Acute Coronary Syndromes: Unraveling the Cardiovascular Burden in Mainland ChinaA nationwide Chinese study reveals that exposure to tropical cyclones increases acute coronary syndrome risk by 14%, delays treatment times, and disproportionately affects vulnerable populations. Coordinated public health and clinical stratSep 12, 2026